Estrogen Deprivation Results in Altered DNA Methylation Profile in Breast Cancer Cells - Role in Endocrine Resistance?

被引：0
|
作者：
Pathiraja, T. N.
Xi, Y.
Lee, A., V
Santen, R.
Gannon, F.
Kaipparettu, B.
Chang, J.
Li, W.
Oesterreich, S.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Virginia Hlth Sci Syst, Charlottesville, VA USA
[3] EMBL, Heidelberg, Germany
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：808S / 808S
页数：1
相关论文
共 50 条
  • [31] Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
    Schiff, R
    Massarweh, SA
    Shou, J
    Bharwani, L
    Arpino, G
    Rimawi, M
    Osborne, CK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (Suppl 1) : S10 - S20
  • [32] Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
    Rachel Schiff
    Suleiman A. Massarweh
    Jiang Shou
    Lavina Bharwani
    Grazia Arpino
    Mothaffar Rimawi
    C. Kent Osborne
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 10 - 20
  • [33] Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
    Marion T Weigel
    Zara Ghazoui
    Anita Dunbier
    Sunil Pancholi
    Mitch Dowsett
    Lesley-Ann Martin
    Breast Cancer Research, 14
  • [34] Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
    Weigel, Marion T.
    Ghazoui, Zara
    Dunbier, Anita
    Pancholi, Sunil
    Dowsett, Mitch
    Martin, Lesley-Ann
    BREAST CANCER RESEARCH, 2012, 14 (03):
  • [35] High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
    Traphagen, Nicole A.
    Hosford, Sarah R.
    Jiang, Amanda
    Marotti, Jonathan D.
    Brauer, Brooke L.
    Demidenko, Eugene
    Miller, Todd W.
    ONCOGENE, 2021, 40 (19) : 3408 - 3421
  • [36] High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
    Nicole A. Traphagen
    Sarah R. Hosford
    Amanda Jiang
    Jonathan D. Marotti
    Brooke L. Brauer
    Eugene Demidenko
    Todd W. Miller
    Oncogene, 2021, 40 : 3408 - 3421
  • [37] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
  • [38] Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells
    Verde, Gaetano
    De Llobet, Lara, I
    Wright, Roni H. G.
    Quilez, Javier
    Peiro, Sandra
    Le Dily, Francois
    Beato, Miguel
    CANCERS, 2018, 10 (10):
  • [39] Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
    Robert Clarke
    Minetta C Liu
    Kerrie B Bouker
    Zhiping Gu
    Richard Y Lee
    Yuelin Zhu
    Todd C Skaar
    Bianca Gomez
    Kerry O'Brien
    Yue Wang
    Leena A Hilakivi-Clarke
    Oncogene, 2003, 22 : 7316 - 7339
  • [40] Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
    Clarke, R
    Liu, MC
    Bouker, KB
    Gu, ZP
    Lee, RY
    Zhu, YL
    Skaar, TC
    Gomez, B
    O'Brien, K
    Wang, Y
    Hilakivi-Clarke, L
    ONCOGENE, 2003, 22 (47) : 7316 - 7339
12345